Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 2000;101:510 5. S7.9.1.3-29. Shimeno K, Takagi M, Maeda K, et al. Usefulness of multichannel Holter ECG recording in the third intercostal space for detecting type 1 Brugada ECG: comparison with repeated 12-lead ECGs. J Cardiovasc Electrophysiol. 2009;20:1026 31. S7.9.1.3-30. Conte G, Sieira J, Ciconte G, et al. Implantable cardioverter-defi- brillator therapy in Brugada syndrome: a 20-year single-center experience. J Am Coll Cardiol. 2015;65:879 88. S7.9.1.3-31. Kapplinger JD, Tester DJ, Alders M, et al. An international com- pendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic test- ing. Heart Rhythm. 2010;7:33 46. S7.9.1.3-32. Adler A, Rosso R, Chorin E, et al. Risk stratification in Brugada syn- drome: clinical characteristics, electrocardiographic parameters, and auxiliary testing. Heart Rhythm. 2016;13:299 310. S7.9.1.3-33. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and manage- ment. Circulation. 2002;105:1342 7. 7.9.1.4. Early Repolarization J-wave Syndrome S7.9.1.4-1. Rosso R, Kogan E, Belhassen B, et al. J-point elevation in sur- vivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol. 2008;52:1231 8. S7.9.1.4-2. Adhikarla C, Boga M, Wood AD, et al. Natural history of the electrocardiographic pattern of early repolarization in ambulatory patients. Am J Cardiol. 2011;108:1831 5. S7.9.1.4-3. Haissaguerre M, Sacher F, Nogami A, et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol. 2009;53:612 9. S7.9.1.4-4. Siebermair J, Sinner MF, Beckmann BM, et al. Early repolariza- tion pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years. Europace. 